The US announced plans to share 60M doses of AstraZeneca’s coronavirus vaccine internationally once the vaccine receives sign-off from US regulators. The vaccine has not yet received FDA authorization, and officials noted that the US likely will not need the vaccine in the coming months (due to existing supply of the three currently approved vaccines).
The New Paper
This story is from the April 26, 2021 edition of The New Paper – a clear, concise daily briefing that makes fact-first news easy to consume. Try it today.
